Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Epic plans to expand the role of artificial intelligence across its EHR platform in 2026, with a focus on embedding AI directly into ...
Oracle still looks more like a hold than a sell, with fast‑growing cloud and AI revenue and a Street “Moderate Buy” rating with about 70% implied upside.
As health systems contend with financial pressures, workforce shortages and rising expectations for digital access, Meditech is positioning Expanse as ...